Home
Class 12
BIOLOGY
Match the following {:("Gene interacti...

Match the following
`{:("Gene interactions",F_2 "Phenotype ratio"),("(A) Complementary genes",(i) 1:2:1),("(B) Supplementary genes",(ii) 9 : 7),("(C) Co - dominance ",(iii) 15 :1),("(D) Duplicate genes",(iv) 9 :3:4):}`

A

A-(iv), B-(iii),C-(i), D-(ii)

B

A-(ii),B-(iv),C-(i),D-(iii)

C

A-(iii),B-(iv),C-(ii),D-(i)

D

A-(iii),B-(i),C-(iv),D-(i)

Text Solution

Verified by Experts

Promotional Banner

Topper's Solved these Questions

  • SAMPLE PAPER -03

    FULL MARKS|Exercise BIO-BOTANY (PART -II )|7 Videos

  • SAMPLE PAPER -03

    FULL MARKS|Exercise BIO-BOTANY ( PART -III)|5 Videos

  • SAMPLE PAPER - 2

    FULL MARKS|Exercise PART - IV|8 Videos

  • SAMPLE PAPER -17

    FULL MARKS|Exercise ZOOLOGY (PART - IV )|4 Videos

Similar Questions

Explore conceptually related problems

Match the following : {:("Epistatic interaction","Example"),("(A) Complementary genes","(i) Seed capsule in xxxxx"),("(B) Supplementary genes","(ii) Leaf color in rice plant"),("(C) Inhibitory genes","(iii) Grain color in maize"),("(D) Duplicate genes","(iv) Flower color in sweet peas"):}

In which one of the following, complementary gene interaction ratio of 9:7 is observed?

Match the following : {:("(1) Conidia ","(i) Yeast"),("(2) Budding ","(ii) Bacteria "),("(3) Gamma cups","(iii) Aspergillus"),("(4) Binary fission","(iv) Marchantia"):}

Match the following : {:("Column I","Column II"),(1."Work","(i) Supplementary unit in SI system"),(2."Torque","(ii)Kinematics"),(3."Plane angle","(iii)Motion"),(4."Meaning of Kinema","(iv)Vector"),(,"(v)Scalar"):}

Write the F_(2) phenotypic ratio of (i) Recessive epistasis (ii) Duplicate genes

Show that the following points taken in order form the vertices of a parallelogram. (i) A(-3,1) , B(-6,-7) ,C(3,-9) and D(6,-1) (ii) A(-7,-3),B(5,10),C(15,8) and D(3,-5)

Which of the following processes/techniques can be included under biotechnology ? (i) In vitro fertilisation (ii) Synthesis of a gene (iii) Correcting a defective gene (iv) Developing a DNA vaccine